| 51.50 |  -0.06 / -0.12% |
Data as of 4:01pm ET | Day’s Change |
| 51.53 |  +0.03 / +0.06% |
Volume: 42,000 |
The 30 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 49.35, with a high estimate of 56.31 and a low estimate of 39.73. The median estimate represents a -4.18% decrease from the last price of 51.50.
The current consensus among 37 polled investment analysts is to Hold stock in AstraZeneca PLC. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.
.
